02509.HK
Qyuns Therapeutics Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 16.44
−1.73%Margins
Gross margin
88.6%
EBITDA margin
56.7%
EBIT margin
54.5%
Net margin
53.3%
FCF margin
50.4%
63.4%
Return on equity
28.6%
Return on assets
36.1%
Return on invested capital
0.54x
Asset turnover
HKD 605.9M
Cash from operations
HKD 5.43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026